title: Suppressing oncogenic transcription with a little healthy competition.
abstract: Therapeutic strategies that stabilize wild-type MLL proteins have selective activity in MLL-rearranged leukemias.
authors.affiliation: Department of Pharmacology and Cancer Biology, Duke University, Durham, NC 27710, USA. Email: kris.wood@duke.edu.
authors.forename: Kris C
authors.initials: KC
authors.lastname: Wood
mesh_terms: D063646:Carcinogenesis; D015973:Gene Expression Regulation, Leukemic; D011495:Histone-Lysine N-Methyltransferase; D006801:Humans; D007938:Leukemia / Q000235:genetics*; D051788:Myeloid-Lymphoid Leukemia Protein / Q000235:genetics; D009857:Oncogenes
chemical_list: C497422:KMT2A protein, human; D051788:Myeloid-Lymphoid Leukemia Protein; D011495:Histone-Lysine N-Methyltransferase